Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2021-08-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
半年报董事会决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolutions from the 15th meeting of the 6th Board of Directors of 嘉事堂药业股份有限公司. It specifically mentions the approval of the 2021 half-year report and its summary, including financial figures for the first half of 2021. However, the document itself does not contain the full half-year report but refers to it being available on external websites. The document length is short (845 characters), and it serves as a formal announcement of the board meeting decisions and the approval of the interim report rather than the report itself. According to the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement about board resolutions and report approval without containing the full financial report data.
2021-08-26 Chinese
嘉事堂药业股份有限公司2021年度风险偏好陈述书（年中修订稿）
Environmental & Social Information Classification · 85% confidence The document is titled '2021 年度风险偏好陈述书（年中修订稿）' which translates to '2021 Annual Risk Appetite Statement (Mid-year Revised Draft)'. It is a detailed statement about the company's risk appetite, including qualitative and quantitative risk indicators for the year 2021. The content focuses on risk management policies, risk categories, and specific risk metrics rather than financial results or earnings. The document length is 3315 characters, which is relatively short but contains substantive content about risk preferences and management rather than being a brief announcement or a certification. It is not an annual report, earnings release, or regulatory filing. It is a specialized report on risk appetite, which aligns with the category of Environmental & Social Information (ESG) or risk management disclosures. Given the available categories, the closest match is Environmental & Social Information (SR), as it covers the company's performance on governance and risk management aspects related to ESG factors. Therefore, the document is best classified as Environmental & Social Information (SR).
2021-08-12 Chinese
关于变更内审部负责人的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding a change in the head of the internal audit department of the company 嘉事堂药业股份有限公司. It details the appointment of a new internal audit head, including her resume and qualifications. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no shareholder voting results. The content is about management changes specifically related to a senior internal audit position. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2021-08-12 Chinese
第6届董事会第14次临时会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the 14th extraordinary meeting of the 6th Board of Directors of 嘉事堂药业股份有限公司. It details changes in senior management positions such as the appointment of a new president and vice presidents, as well as changes in internal audit leadership. The document also mentions revisions to the company's risk preference statement and strategic plan. The content focuses on board and management decisions and appointments, which aligns with the category of Board/Management Information. The document is relatively short (1896 characters) and is a formal announcement of board decisions rather than a full report or detailed financial disclosure. Therefore, the appropriate classification is MANG (Board/Management Information).
2021-08-12 Chinese
关于聘任公司副总裁的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of two individuals as vice presidents of the company. It includes their resumes and confirms their qualifications and lack of conflicts of interest. There is no financial data, no mention of financial results, no regulatory filings, or other report types. The content is about changes in senior management positions, which fits the category of Board/Management Information (MANG). The document length is short and focused solely on management appointments, confirming the classification.
2021-08-12 Chinese
关于公司董事长不兼任总裁及聘任总裁的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding a change in the company's senior management, specifically the appointment of a new president and the chairman not concurrently serving as president. It includes biographical details of the appointed individual and compliance statements about his qualifications and legal standing. There is no financial data, no mention of financial results, no regulatory filings or report attachments. The content fits the category of Board/Management Information (MANG) as it concerns changes in senior management positions.
2021-08-12 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.